Kassem Bourgi, MD

Assistant Professor
Indiana University School of Medicine
Indianapolis, IN

Disclosure: Gilead Sciences: Grant/Research Support

Presentation(s):

• LB9 - The Effect of Initiating Integrase Inhibitor-based vs. Non-Nucleoside Reverse Transcriptase Inhibitor-based Antiretroviral Therapy on Progression to Diabetes among North American Persons in HIV Care

  Friday, October 4
  1:55 PM – 2:05 PM